Sissetulev kiriAvalik
Inquiry
Ravimiamet · 29. juuli 2024
- Viit
- RST-1/2739-1
- Registreeritud
- 29. juuli 2024
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- DatamedIQ GmbH
- Saabumis/saatmisviis
- e-post
- Funktsioon
- RST Ravimistatistika tegemine
- Sari
- RST-1 Ravimistatistika alane kirjavahetus
- Toimik
- RST-1/2024
- Vastutaja
- Marju Sammul (RA, Ravimiohutuse osakond, Statistikabüroo)
- Lahendamise tähtaeg
- 6. aprill 2024
Failid
Sisu (failidest)
Saatja: "Marju Sammul" <[email protected]>
Saaja: "Dominique Ziegelmayer" <[email protected]>
Teema: RE: Information about the Estonian ePharmacy-Market
Kuupäev: 2024-03-11 07:32
From: Dominique Ziegelmayer < <mailto:[email protected]>
[email protected]>
Sent: neljapäev, 7. märts 2024 13:56
To: Ravimiamet < <mailto:[email protected]> [email protected]>
Subject: Information about the Estonian ePharmacy-Market
Dear Sirs and Maddams,
We are trying to compile a report on the different pharmaceutical markets in
the EU. Can you give us information about the online-market share (rx and
nonRx if possible) and the growth of the online Pharmacy-market in Estonia?
Mit freundlichen Grüßen / Best Regards
Dominique Ziegelmayer
<https://datamediq.com/>
Dr. Dominique Ziegelmayer
Chief Executive Officer (CEO)
T : +49 221 999 895 20
Im Mediapark 4b, 50670 Köln
datamediq.com
🍸 Save The Date: Insights On The Rocks - 12.06.2024
<https://meetings-eu1.hubspot.com/dominique-ziegelmayer>
<https://data.sigilium.com/signatures/rcxcojvf6uq6awshivhdhrvmr0534rc/link>
<https://www.linkedin.com/company/datamediq/>
<https://www.instagram.com/datamediq/>
<https://data.sigilium.com/signatures/rcxcojvf6uq6awshivhdhrvmr0534rc/redirect_link>
DatamedIQ GmbH | Sitz: Köln, Amtsgericht Köln HRB 96213
Geschäftsführer: Dr. Dominique Ziegelmayer